Wanbury Limited
NSE:WANBURY.NS
265.52 (INR) • At close September 19, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Wanbury Limited |
Symbool | WANBURY.NS |
Munteenheid | INR |
Prijs | 265.52 |
Beurswaarde | 8,694,585,160 |
Dividendpercentage | 0% |
52-weken bereik | 60 - 270 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. K. Chandran |
Website | https://www.wanbury.com |
An error occurred while fetching data.
Over Wanbury Limited
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)